PLA2G7 and atherosclerosis: Newly described inflammation mediators, such as lipoprotein-associated phospholipase A2 (Lp-PLA2) and YKL-40, are highly expressed in atherosclerotic plaques and contribute significantly to the progression of atherosclerosis [2].